/
BIOVF
$48.00+$0.52 (+1.11%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$28.94 – $48.00
100% from low
Exchange
OTC Link
OS
Price (6 mo)
Loading chart…
Change+$27.96
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.14B | $14.25B | $15.26B | $15.53B | $18.79B | $22.12B | $26.03B | $28.17B |
| Cost of revenue | $2.42B | $3.33B | $3.23B | $3.48B | $4.78B | $5.00B | $5.79B | $15.88B |
| Gross profit | $6.72B | $10.91B | $12.04B | $12.04B | $14.01B | $17.13B | $20.24B | $12.29B |
| Gross margin | 73.6% | 76.6% | 78.9% | 77.6% | 74.6% | 77.4% | 77.8% | 43.6% |
| R&D | $1.09B | $1.50B | $1.59B | $1.99B | $2.35B | $2.80B | $3.54B | $3.24B |
| Operating income | $3.12B | $4.53B | $4.82B | $3.73B | $3.81B | $4.07B | $5.63B | $8.03B |
| EBITDA | $3.62B | $6.00B | $6.69B | $5.72B | $6.05B | $7.23B | $9.30B | $10.94B |
| Net income | $2.42B | $3.30B | $3.25B | $2.68B | $2.64B | $2.41B | $3.88B | $476.8M |
| Net margin | 26.5% | 23.2% | 21.3% | 17.3% | 14.0% | 10.9% | 14.9% | 1.7% |
| EPS (diluted) | 8.93 | 10.72 | 10.41 | 8.62 | 8.44 | 7.39 | 11.24 | 1.38 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $32.0B | $18.26 | $17.43–$19.17 | 1 |
| 2027 | $36.5B | $23.39 | $22.33–$24.56 | 1 |
| 2028 | $40.5B | $26.28 | $25.09–$27.60 | 1 |
| 2029 | $45.5B | $28.92 | $27.61–$30.37 | 1 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$148.90
Price
$48.00
Implied upside
+210%
Peer comparison
SWEDISH ORPHAN BIOVIT ORD
SWEDISH ORPHAN BIOVIT ORD
Held by traders on TradeandTell
No one on the platform currently holds BIOVF.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in BIOVF as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded BIOVF yet.